These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21111102)

  • 21. Human chorionic gonadotrophin.
    Bradley P
    Med J Aust; 1976 Sep; 2(13):510-1. PubMed ID: 994948
    [No Abstract]   [Full Text] [Related]  

  • 22. Oleoyl-estrone metabolic effects in relation with caloric restriction in inbred Beta rats with spontaneous obesity and type 2 diabetes.
    Posadas MD; Olguín MC; Zingale MI; Revelant G; Labourdette V; Gayol Mdel C; Calderari S
    Medicina (B Aires); 2004; 64(4):332-6. PubMed ID: 15338976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity.
    Yanovski SZ; Yanovski JA
    N Engl J Med; 2002 Feb; 346(8):591-602. PubMed ID: 11856799
    [No Abstract]   [Full Text] [Related]  

  • 24. New weight loss product.
    Health News; 2000 Jun; 6(6):7. PubMed ID: 10865521
    [No Abstract]   [Full Text] [Related]  

  • 25. "There they go again"--hCG and weight loss.
    Toffle RC
    W V Med J; 2011; 107(1):12-3. PubMed ID: 21322466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gonadic and extragonadic effects in humans of 3,500 I.U. of HCG (human chorionic gonadotropin) in fractional doses].
    Veilleux H; Fortin Z
    Vie Med Can Fr; 1972 Sep; 1(9):862-71. PubMed ID: 4654984
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypertension in obesity: its epidemiology, physiopathology and treatment efforts].
    Sharma AM; Moeller T; Engeli S
    Dtsch Med Wochenschr; 1999 Nov; 124(45):1337-41. PubMed ID: 10592777
    [No Abstract]   [Full Text] [Related]  

  • 28. 'The equilibrium set-point weight: human chorionic gonadotrophin and obesity'.
    Bradley P
    Int J Obes; 1979; 3(4):380-9. PubMed ID: 528136
    [No Abstract]   [Full Text] [Related]  

  • 29. [Weight loss treatment of obese type 2 diabetic patients].
    Madsbad S; Richelsen B
    Ugeskr Laeger; 2006 Jan; 168(2):175-9. PubMed ID: 16403345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical consequence of human chorionic gonadotropin misuse.
    Pektezel MY; Bas DF; Topcuoglu MA; Arsava EM
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):e17-9. PubMed ID: 25440322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human chorionic gonadotropin (HCG) in treatment of obesity.
    Hutton JH; Creticos AP
    IMJ Ill Med J; 1967 Nov; 132(5):693-5. PubMed ID: 4383998
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacotherapy of obesity].
    Svendsen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach.
    Freemark M
    Diabetes Care; 2007 Feb; 30(2):395-402. PubMed ID: 17259519
    [No Abstract]   [Full Text] [Related]  

  • 34. [Past, present and future of obesity pharmacotherapy].
    Fábryová L
    Vnitr Lek; 2010 Oct; 56(10):1058-64. PubMed ID: 21105452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight loss testimonials: a critique of potential FTC restrictions on diet advertising.
    Nguyen ES
    Food Drug Law J; 2008; 63(2):493-507. PubMed ID: 18561474
    [No Abstract]   [Full Text] [Related]  

  • 36. JAMA PATIENT PAGE. Specific Medications for Weight Loss.
    Jin J
    JAMA; 2015 Aug; 314(7):742. PubMed ID: 26284734
    [No Abstract]   [Full Text] [Related]  

  • 37. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCG not approved for use in obesity.
    Behav Neuropsychiatry; 1975 Apr-1976 Mar; 7(1-12):4. PubMed ID: 1235847
    [No Abstract]   [Full Text] [Related]  

  • 39. Behavioral interventions for obesity.
    Berkel LA; Poston WS; Reeves RS; Foreyt JP
    J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S35-43. PubMed ID: 15867894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
    Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.